| Bioactivity | APL180 TFA (L-4F) is an apolipoprotein AI mimetic peptide that enhances the anti-inflammatory activity of high-density lipoprotein (HDL). APL180 can be used in the study of cardiovascular diseases. | ||||||
| Sequence | Ac-Asp-Trp-Phe-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Phe-Lys-Glu-Ala-Phe-NH2 | ||||||
| Shortening | Ac-DWFKAFYDKVAEKFKEAF-NH2 | ||||||
| Formula | C114H156N24O28.xC2HF3O2 | ||||||
| Molar Mass | 2310.60 (free base) | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||
| Reference | [1]. Watson CE, et al. Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. J Lipid Res. 2011 Feb;52(2):361-73. |
APL180 TFA
CAS: F: C114H156N24O28.xC2HF3O2 W: 2310.60 (free base)
APL180 TFA (L-4F) is an apolipoprotein AI mimetic peptide that enhances the anti-inflammatory activity of high-density l
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.